Skip to main content

Diagnostic options Β· UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 16–30 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5794
ABCA1 Gene Tangier Disease Genetic Test

This test evaluates the ABCA1 gene for pathogenic variants associated with Tangier disease.

Whole blood in EDTA 3–4 weeks (21–28 business days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCA1 gene coding region", "ABCA1 gene splice-site junctions"]
Parameters
[]
Preparation
["12-hour fast recommended if a concurrent lipid panel is ordered"]
Indications
["Suspected Tangier disease", "Family history of Tangier disease", "Severe HDL deficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94040-0 ICD-10: E78.6
Clinical summary
This test evaluates the ABCA1 gene for pathogenic variants associated with Tangier disease.
TEST-4954
ABCA12 Gene Lamellar Ichthyosis Type 2 Genetic Test

This test identifies pathogenic variants within the ABCA12 gene, confirming a diagnosis of lamellar ichthyosis type 2.

Peripheral whole blood (EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCA12 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No special dietary restrictions", "Pre-test genetic counselling session required"]
Indications
["Suspected diagnosis of lamellar ichthyosis type 2", "Differential diagnosis of congenital ichthyoses", "Carrier detection in families with affected individuals", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 10334-7 ICD-10: Q80.2, Q80.0
Clinical summary
This test identifies pathogenic variants within the ABCA12 gene, confirming a diagnosis of lamellar ichthyosis type 2.
TEST-4991
ABCA12 Gene Sequencing (Harlequin Ichthyosis) Test

This test analyzes the ABCA12 gene to detect mutations associated with Harlequin ichthyosis, a severe autosomal recessive skin disorder.

Peripheral Whole Blood (EDTA) 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCA12 gene sequence", "Pathogenic variants (missense, nonsense, frameshift, splice-site, indels)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions (within 4 weeks) or bone marrow/stem cell transplant (within 12 months)"]
Indications
["Suspected Harlequin ichthyosis", "Carrier screening in at-risk individuals", "Prenatal diagnosis in families with known mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81409-9 ICD-10: Q80.4
Clinical summary
This test analyzes the ABCA12 gene to detect mutations associated with Harlequin ichthyosis, a severe autosomal recessive skin disorder.
TEST-5861
ABCA3 Gene Surfactant Metabolism Dysfunction Type 3 Genetic Test

This test evaluates the ABCA3 gene for pathogenic variants associated with Surfactant Metabolism Dysfunction Type 3.

Peripheral whole blood (2–5 mL in EDTA tube) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCA3 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counseling session", "Three-generation pedigree chart construction"]
Indications
["Suspected Surfactant Metabolism Dysfunction Type 3", "Neonatal respiratory distress", "Carrier screening", "Prenatal planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94251-2 ICD-10: J84.81
Clinical summary
This test evaluates the ABCA3 gene for pathogenic variants associated with Surfactant Metabolism Dysfunction Type 3.
TEST-6121
ABCB1 Gene Colchicine Resistance Genetic Test

This genetic test evaluates variants in the ABCB1 gene that influence an individual's response to colchicine medication.

Peripheral whole blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCB1 gene variants", "Colchicine transport efficiency"]
Parameters
[]
Preparation
[]
Indications
["Patients with gout or Familial Mediterranean Fever experiencing suboptimal colchicine efficacy.", "Personalized colchicine dosing guidance."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81616-3 ICD-10: Z13.89
Clinical summary
This genetic test evaluates variants in the ABCB1 gene that influence an individual's response to colchicine medication.
TEST-4862
ABCB1 Gene Inflammatory Bowel Disease Type 13 Genetic Test

This test evaluates the ABCB1 gene for pathogenic variants associated with increased susceptibility to Inflammatory Bowel Disease type 13.

Whole Blood (venous) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCB1 gene", "P-glycoprotein function related to IBD risk"]
Parameters
[]
Preparation
["No specific fasting required.", "Continue normal diet and medications unless advised otherwise by your doctor."]
Indications
["Assessment of genetic susceptibility to IBD type 13", "Personalized risk stratification for Crohn's disease and ulcerative colitis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21646-6 ICD-10: Z15.09
Clinical summary
This test evaluates the ABCB1 gene for pathogenic variants associated with increased susceptibility to Inflammatory Bowel Disease type 13.
TEST-6194
ABCB11 Gene Sequencing for Benign Recurrent Intrahepatic Cholestasis Type 2 (BRIC2) Test

This test evaluates the ABCB11 gene for pathogenic variants associated with Benign Recurrent Intrahepatic Cholestasis Type 2 (BRIC2).

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCB11 gene sequence", "Pathogenic variants in ABCB11"]
Parameters
[]
Preparation
["Pre-test genetic counseling is mandatory"]
Indications
["Recurrent cholestatic episodes", "Family history of BRIC2", "Unexplained cholestasis triggered by pregnancy or oral contraceptives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83900-7 ICD-10: K83.1, Z13.228
Clinical summary
This test evaluates the ABCB11 gene for pathogenic variants associated with Benign Recurrent Intrahepatic Cholestasis Type 2 (BRIC2).
TEST-6100
ABCB4 Gene (Intrahepatic Cholestasis of Pregnancy Type 3) Next‑Generation Sequencing (Genetic Test

This genetic test analyzes the ABCB4 gene for pathogenic variants causing intrahepatic cholestasis of pregnancy type 3 (ICP3). It detects single nucleotide variants, small insertio...

Whole Blood (Peripheral Venous) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCB4 gene pathogenic variants", "Single nucleotide variants", "Small insertions or deletions", "Copy-number variations"]
Parameters
[]
Preparation
["No specific fasting required", "Continue prescribed medications unless advised otherwise by your doctor"]
Indications
["Pregnant women with unexplained pruritus and elevated bile acids", "Individuals with a family history of severe ICP or early-onset disease", "Genetic counselling prior to testing is mandatory"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21671-4 ICD-10: O26.619
Clinical summary
This genetic test analyzes the ABCB4 gene for pathogenic variants causing intrahepatic cholestasis of pregnancy type 3 (ICP3). It detects single nucleotide variants, small insertions/deletions, and copy-number variations across the entire coding region.
TEST-6319
ABCB4 Gene Gallbladder Disease Type 1 Genetic Test

This test identifies pathogenic mutations in the ABCB4 gene associated with low phospholipid-associated cholelithiasis (LPAC) syndrome.

Peripheral Whole Blood 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCB4 gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Patients with recurrent gallstones of unknown etiology", "Patients with a documented family history of ABCB4-related disease", "Patients with unexplained biliary symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-5 ICD-10: K80.80
Clinical summary
This test identifies pathogenic mutations in the ABCB4 gene associated with low phospholipid-associated cholelithiasis (LPAC) syndrome.
TEST-6202
ABCB4 Gene Progressive Familial Intrahepatic Cholestasis Type 3 (PFIC3) Genetic Test

This test identifies pathogenic variants in the ABCB4 gene associated with Progressive Familial Intrahepatic Cholestasis Type 3 (PFIC3).

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCB4 gene coding region", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of PFIC3", "Family risk assessment for PFIC3", "Unexplained cholestasis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81273-7 ICD-10: K76.89, K83.1, Z83.79
Clinical summary
This test identifies pathogenic variants in the ABCB4 gene associated with Progressive Familial Intrahepatic Cholestasis Type 3 (PFIC3).
TEST-5244
ABCB6 Gene Dyschromatosis Universalis Hereditaria Type 3 Genetic Test

This genetic test analyzes the ABCB6 gene to identify pathogenic variants associated with Dyschromatosis Universalis Hereditaria (DUH) type 3.

Whole Blood (EDTA) or Buccal Swab 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCB6 gene coding region", "Pathogenic variants (SNVs, indels, copy number variants)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of Dyschromatosis Universalis Hereditaria (DUH) type 3", "Family screening for inherited pigmentary disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q82.8, L81.9
Clinical summary
This genetic test analyzes the ABCB6 gene to identify pathogenic variants associated with Dyschromatosis Universalis Hereditaria (DUH) type 3.
TEST-6229
ABCC8 Gene Genetic Test for Noninsulin-Dependent Diabetes Mellitus (Type 2 Diabetes)

This genetic test evaluates the ABCC8 gene for pathogenic variants associated with impaired insulin secretion and increased risk for type 2 diabetes and MODY.

Peripheral Whole Blood (EDTA) or DNA FTA Card 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCC8 gene", "Glucose-dependent insulin release regulation"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet changes needed"]
Indications
["Suspected monogenic diabetes (MODY)", "Differentiation of type 2 diabetes from monogenic forms", "Risk stratification for diabetes", "Personalised treatment planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21621-4 ICD-10: E11.9
Clinical summary
This genetic test evaluates the ABCC8 gene for pathogenic variants associated with impaired insulin secretion and increased risk for type 2 diabetes and MODY.
TEST-3008
ABCC9 Gene CantΓΊ Syndrome Genetic Test

This genetic test evaluates the ABCC9 gene for pathogenic variants associated with CantΓΊ syndrome.

Peripheral whole blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCC9 gene", "Single nucleotide variants", "Small insertions/deletions", "Splice-site alterations"]
Parameters
[]
Preparation
["A pre-test genetic counselling session with a pedigree chart is mandatory.", "No fasting or medication changes are needed unless instructed by a physician."]
Indications
["Suspected CantΓΊ syndrome based on clinical presentation", "Family history of CantΓΊ syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48004-6 ICD-10: Q87.8, Q87.0
Clinical summary
This genetic test evaluates the ABCC9 gene for pathogenic variants associated with CantΓΊ syndrome.
TEST-4309
ABCC9 Gene Dilated Cardiomyopathy Type 1O Genetic Test UAE

This genetic test identifies pathogenic variants in the ABCC9 gene associated with dilated cardiomyopathy type 1O.

Whole blood (peripheral) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in ABCC9 gene", "Variants of Uncertain Significance (VUS) in ABCC9 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any relevant medications"]
Indications
["Diagnosis of dilated cardiomyopathy type 1O", "Carrier screening for ABCC9-related cardiomyopathy", "Risk stratification for family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81326-5 ICD-10: I42.0
Clinical summary
This genetic test identifies pathogenic variants in the ABCC9 gene associated with dilated cardiomyopathy type 1O.
TEST-3730
ABCD1 Gene Adrenoleukodystrophy (X-Linked) Test

This test analyzes the ABCD1 gene to detect pathogenic variants associated with X-linked adrenoleukodystrophy (X-ALD). It provides definitive diagnosis and carrier status determina...

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCD1 gene", "Point mutations", "Small insertions/deletions", "Large copy number variations"]
Parameters
[]
Preparation
["A prior genetic counseling appointment is mandatory.", "A detailed three-generation pedigree chart is mandatory."]
Indications
["Suspected X-linked adrenoleukodystrophy (X-ALD)", "Family history of X-ALD", "Carrier screening", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93119-6 ICD-10: E71.52
Clinical summary
This test analyzes the ABCD1 gene to detect pathogenic variants associated with X-linked adrenoleukodystrophy (X-ALD). It provides definitive diagnosis and carrier status determination.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area